Oriflame to transfer India manufacturing operations to Akums subsidiary
Oriflame India will sell its Roorkee and Noida manufacturing operations to Pure and Cure Healthcare, an Akums subsidiary, subject to customary approvals. The beauty brand will retain its commercial operations and Beauty Entrepreneur network under a long-term manufacturing and supply partnership.
What happened
Oriflame India · Oriflame will transfer its Roorkee and Noida manufacturing operations to Akums subsidiary Pure and Cure Healthcare, while retaining India
Key facts
- Undisclosed transaction value
- More than 30 years of Oriflame operations in India
Why this matters
The transaction gives Akums subsidiary Pure and Cure added beauty manufacturing capacity while allowing Oriflame to retain its commercial platform and direct-selling network without owning production assets.
What to watch
- Closing timeline and whether both Roorkee and Noida facilities transfer intact, including employees and equipment.
- Terms of the supply agreement: duration, minimum-volume commitments, exclusivity, pricing-indexation and service-level protections.
- Any regulatory observations, product-registration changes or manufacturing-license transfers.
- SKU-level stock availability, delivery times and seller complaints during the first two quarters after migration.
- Oriflame India revenue growth, active Beauty Entrepreneur count and gross-margin trend following the asset sale.
- Akums disclosures of new cosmetics/personal-care capacity, customer wins or capital expenditure linked to the transaction.
- Complete customary transaction, labor-transfer and manufacturing-license approvals.
- Execute phased technology transfer and product validation for key skincare, color cosmetics and personal-care SKUs.
- Reconfigure Oriflame India's supply-planning, quality-assurance and procurement teams around supplier governance rather than plant operations.
- Prioritize inventory buffers for high-velocity Beauty Entrepreneur products during the transition.
- Akums may invest in dedicated capacity, packaging lines, R&D support and quality systems to secure the long-term account.
- Oriflame is likely to redirect savings toward network activation, digital tools, localized launches and potentially more India-specific product development.